img

Global Orally Disintegrating Tablet Excipient Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Orally Disintegrating Tablet Excipient Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

An orally disintegrating tablet or orally dissolving tablet (ODT) is a drug dosage form available for a limited range of over-the-counter (OTC) and prescription medications.An excipient is a pharmacologically inert adhesive substance used to bind the contents of a pill or tablet. This type of tablet separates in the mouth in contact with saliva, making it easy for a person to swallow the tablet without drinking water.
Orally Disintegrating Tablet Excipient report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Orally Disintegrating Tablet Excipient market is projected to reach US$ 21240 million in 2034, increasing from US$ 16650 million in 2022, with the CAGR of 3.5% during the period of 2024 to 2034. Demand from Anti-Psychotics Drug and Anti-Epileptics Drug are the major drivers for the industry.
McePharma (Vivesa holding) was the global greatest company in Orally Disintegrating Tablet Excipient industry, with the revenue market Share of 3% , followed by BASF, JRS Pharma, Roquette, ABF Ingredients, DFE Pharma, Evonik, Merck KGaA, Ashland, Meggle Pharma, Shin-Etsu, Fuji Chemical Industries, Cargill Incorporated, Daicel Corporation, Anhui Sunhere Pharmaceutical.APAC is the largest Orally Disintegrating Tablet Excipient market with about 30% market share. Americas is follower, accounting for about 27% market share.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Orally Disintegrating Tablet Excipient market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


BASF
JRS Pharma
Roquette
ABF Ingredients
DFE Pharma
Evonik
Merck KGaA
Ashland
Meggle Pharma
Shin-Etsu
Fuji Chemical Industries
McePharma (Vivesa holding)
Cargill Incorporated
Daicel Corporation
Anhui Sunhere Pharmaceutical
Segment by Type
Binders
Glidents
Diluents
Disintegrants
Others

Segment by Application


Anti-Psychotics Drug
Anti-Epileptics Drug
Others

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Orally Disintegrating Tablet Excipient market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Orally Disintegrating Tablet Excipient, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Orally Disintegrating Tablet Excipient industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Orally Disintegrating Tablet Excipient in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Orally Disintegrating Tablet Excipient introduction, etc. Orally Disintegrating Tablet Excipient Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Orally Disintegrating Tablet Excipient market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Orally Disintegrating Tablet Excipient Market Overview
1.1 Orally Disintegrating Tablet Excipient Product Overview
1.2 Orally Disintegrating Tablet Excipient Market Segment by Type
1.2.1 Binders
1.2.2 Glidents
1.2.3 Diluents
1.2.4 Disintegrants
1.2.5 Others
1.3 Global Orally Disintegrating Tablet Excipient Market Size by Type
1.3.1 Global Orally Disintegrating Tablet Excipient Market Size Overview by Type (2018-2034)
1.3.2 Global Orally Disintegrating Tablet Excipient Historic Market Size Review by Type (2018-2024)
1.3.3 Global Orally Disintegrating Tablet Excipient Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Orally Disintegrating Tablet Excipient Sales Breakdown by Type (2018-2024)
1.4.2 Europe Orally Disintegrating Tablet Excipient Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Orally Disintegrating Tablet Excipient Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Orally Disintegrating Tablet Excipient Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Orally Disintegrating Tablet Excipient Sales Breakdown by Type (2018-2024)
2 Global Orally Disintegrating Tablet Excipient Market Competition by Company
2.1 Global Top Players by Orally Disintegrating Tablet Excipient Sales (2018-2024)
2.2 Global Top Players by Orally Disintegrating Tablet Excipient Revenue (2018-2024)
2.3 Global Top Players by Orally Disintegrating Tablet Excipient Price (2018-2024)
2.4 Global Top Manufacturers Orally Disintegrating Tablet Excipient Manufacturing Base Distribution, Sales Area, Product Type
2.5 Orally Disintegrating Tablet Excipient Market Competitive Situation and Trends
2.5.1 Orally Disintegrating Tablet Excipient Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Orally Disintegrating Tablet Excipient Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Orally Disintegrating Tablet Excipient as of 2022)
2.7 Date of Key Manufacturers Enter into Orally Disintegrating Tablet Excipient Market
2.8 Key Manufacturers Orally Disintegrating Tablet Excipient Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Orally Disintegrating Tablet Excipient Status and Outlook by Region
3.1 Global Orally Disintegrating Tablet Excipient Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Orally Disintegrating Tablet Excipient Historic Market Size by Region
3.2.1 Global Orally Disintegrating Tablet Excipient Sales in Volume by Region (2018-2024)
3.2.2 Global Orally Disintegrating Tablet Excipient Sales in Value by Region (2018-2024)
3.2.3 Global Orally Disintegrating Tablet Excipient Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Orally Disintegrating Tablet Excipient Forecasted Market Size by Region
3.3.1 Global Orally Disintegrating Tablet Excipient Sales in Volume by Region (2024-2034)
3.3.2 Global Orally Disintegrating Tablet Excipient Sales in Value by Region (2024-2034)
3.3.3 Global Orally Disintegrating Tablet Excipient Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Orally Disintegrating Tablet Excipient by Application
4.1 Orally Disintegrating Tablet Excipient Market Segment by Application
4.1.1 Anti-Psychotics Drug
4.1.2 Anti-Epileptics Drug
4.1.3 Others
4.2 Global Orally Disintegrating Tablet Excipient Market Size by Application
4.2.1 Global Orally Disintegrating Tablet Excipient Market Size Overview by Application (2018-2034)
4.2.2 Global Orally Disintegrating Tablet Excipient Historic Market Size Review by Application (2018-2024)
4.2.3 Global Orally Disintegrating Tablet Excipient Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Orally Disintegrating Tablet Excipient Sales Breakdown by Application (2018-2024)
4.3.2 Europe Orally Disintegrating Tablet Excipient Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Orally Disintegrating Tablet Excipient Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Orally Disintegrating Tablet Excipient Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Orally Disintegrating Tablet Excipient Sales Breakdown by Application (2018-2024)
5 North America Orally Disintegrating Tablet Excipient by Country
5.1 North America Orally Disintegrating Tablet Excipient Historic Market Size by Country
5.1.1 North America Orally Disintegrating Tablet Excipient Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Orally Disintegrating Tablet Excipient Sales in Volume by Country (2018-2024)
5.1.3 North America Orally Disintegrating Tablet Excipient Sales in Value by Country (2018-2024)
5.2 North America Orally Disintegrating Tablet Excipient Forecasted Market Size by Country
5.2.1 North America Orally Disintegrating Tablet Excipient Sales in Volume by Country (2024-2034)
5.2.2 North America Orally Disintegrating Tablet Excipient Sales in Value by Country (2024-2034)
6 Europe Orally Disintegrating Tablet Excipient by Country
6.1 Europe Orally Disintegrating Tablet Excipient Historic Market Size by Country
6.1.1 Europe Orally Disintegrating Tablet Excipient Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Orally Disintegrating Tablet Excipient Sales in Volume by Country (2018-2024)
6.1.3 Europe Orally Disintegrating Tablet Excipient Sales in Value by Country (2018-2024)
6.2 Europe Orally Disintegrating Tablet Excipient Forecasted Market Size by Country
6.2.1 Europe Orally Disintegrating Tablet Excipient Sales in Volume by Country (2024-2034)
6.2.2 Europe Orally Disintegrating Tablet Excipient Sales in Value by Country (2024-2034)
7 Asia-Pacific Orally Disintegrating Tablet Excipient by Region
7.1 Asia-Pacific Orally Disintegrating Tablet Excipient Historic Market Size by Region
7.1.1 Asia-Pacific Orally Disintegrating Tablet Excipient Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Orally Disintegrating Tablet Excipient Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Orally Disintegrating Tablet Excipient Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Orally Disintegrating Tablet Excipient Forecasted Market Size by Region
7.2.1 Asia-Pacific Orally Disintegrating Tablet Excipient Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Orally Disintegrating Tablet Excipient Sales in Value by Region (2024-2034)
8 Latin America Orally Disintegrating Tablet Excipient by Country
8.1 Latin America Orally Disintegrating Tablet Excipient Historic Market Size by Country
8.1.1 Latin America Orally Disintegrating Tablet Excipient Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Orally Disintegrating Tablet Excipient Sales in Volume by Country (2018-2024)
8.1.3 Latin America Orally Disintegrating Tablet Excipient Sales in Value by Country (2018-2024)
8.2 Latin America Orally Disintegrating Tablet Excipient Forecasted Market Size by Country
8.2.1 Latin America Orally Disintegrating Tablet Excipient Sales in Volume by Country (2024-2034)
8.2.2 Latin America Orally Disintegrating Tablet Excipient Sales in Value by Country (2024-2034)
9 Middle East and Africa Orally Disintegrating Tablet Excipient by Country
9.1 Middle East and Africa Orally Disintegrating Tablet Excipient Historic Market Size by Country
9.1.1 Middle East and Africa Orally Disintegrating Tablet Excipient Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Orally Disintegrating Tablet Excipient Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Orally Disintegrating Tablet Excipient Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Orally Disintegrating Tablet Excipient Forecasted Market Size by Country
9.2.1 Middle East and Africa Orally Disintegrating Tablet Excipient Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Orally Disintegrating Tablet Excipient Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 BASF
10.1.1 BASF Company Information
10.1.2 BASF Introduction and Business Overview
10.1.3 BASF Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2018-2024)
10.1.4 BASF Orally Disintegrating Tablet Excipient Products Offered
10.1.5 BASF Recent Development
10.2 JRS Pharma
10.2.1 JRS Pharma Company Information
10.2.2 JRS Pharma Introduction and Business Overview
10.2.3 JRS Pharma Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2018-2024)
10.2.4 JRS Pharma Orally Disintegrating Tablet Excipient Products Offered
10.2.5 JRS Pharma Recent Development
10.3 Roquette
10.3.1 Roquette Company Information
10.3.2 Roquette Introduction and Business Overview
10.3.3 Roquette Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Roquette Orally Disintegrating Tablet Excipient Products Offered
10.3.5 Roquette Recent Development
10.4 ABF Ingredients
10.4.1 ABF Ingredients Company Information
10.4.2 ABF Ingredients Introduction and Business Overview
10.4.3 ABF Ingredients Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2018-2024)
10.4.4 ABF Ingredients Orally Disintegrating Tablet Excipient Products Offered
10.4.5 ABF Ingredients Recent Development
10.5 DFE Pharma
10.5.1 DFE Pharma Company Information
10.5.2 DFE Pharma Introduction and Business Overview
10.5.3 DFE Pharma Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2018-2024)
10.5.4 DFE Pharma Orally Disintegrating Tablet Excipient Products Offered
10.5.5 DFE Pharma Recent Development
10.6 Evonik
10.6.1 Evonik Company Information
10.6.2 Evonik Introduction and Business Overview
10.6.3 Evonik Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Evonik Orally Disintegrating Tablet Excipient Products Offered
10.6.5 Evonik Recent Development
10.7 Merck KGaA
10.7.1 Merck KGaA Company Information
10.7.2 Merck KGaA Introduction and Business Overview
10.7.3 Merck KGaA Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Merck KGaA Orally Disintegrating Tablet Excipient Products Offered
10.7.5 Merck KGaA Recent Development
10.8 Ashland
10.8.1 Ashland Company Information
10.8.2 Ashland Introduction and Business Overview
10.8.3 Ashland Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Ashland Orally Disintegrating Tablet Excipient Products Offered
10.8.5 Ashland Recent Development
10.9 Meggle Pharma
10.9.1 Meggle Pharma Company Information
10.9.2 Meggle Pharma Introduction and Business Overview
10.9.3 Meggle Pharma Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Meggle Pharma Orally Disintegrating Tablet Excipient Products Offered
10.9.5 Meggle Pharma Recent Development
10.10 Shin-Etsu
10.10.1 Shin-Etsu Company Information
10.10.2 Shin-Etsu Introduction and Business Overview
10.10.3 Shin-Etsu Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Shin-Etsu Orally Disintegrating Tablet Excipient Products Offered
10.10.5 Shin-Etsu Recent Development
10.11 Fuji Chemical Industries
10.11.1 Fuji Chemical Industries Company Information
10.11.2 Fuji Chemical Industries Introduction and Business Overview
10.11.3 Fuji Chemical Industries Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Fuji Chemical Industries Orally Disintegrating Tablet Excipient Products Offered
10.11.5 Fuji Chemical Industries Recent Development
10.12 McePharma (Vivesa holding)
10.12.1 McePharma (Vivesa holding) Company Information
10.12.2 McePharma (Vivesa holding) Introduction and Business Overview
10.12.3 McePharma (Vivesa holding) Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2018-2024)
10.12.4 McePharma (Vivesa holding) Orally Disintegrating Tablet Excipient Products Offered
10.12.5 McePharma (Vivesa holding) Recent Development
10.13 Cargill Incorporated
10.13.1 Cargill Incorporated Company Information
10.13.2 Cargill Incorporated Introduction and Business Overview
10.13.3 Cargill Incorporated Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2018-2024)
10.13.4 Cargill Incorporated Orally Disintegrating Tablet Excipient Products Offered
10.13.5 Cargill Incorporated Recent Development
10.14 Daicel Corporation
10.14.1 Daicel Corporation Company Information
10.14.2 Daicel Corporation Introduction and Business Overview
10.14.3 Daicel Corporation Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2018-2024)
10.14.4 Daicel Corporation Orally Disintegrating Tablet Excipient Products Offered
10.14.5 Daicel Corporation Recent Development
10.15 Anhui Sunhere Pharmaceutical
10.15.1 Anhui Sunhere Pharmaceutical Company Information
10.15.2 Anhui Sunhere Pharmaceutical Introduction and Business Overview
10.15.3 Anhui Sunhere Pharmaceutical Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2018-2024)
10.15.4 Anhui Sunhere Pharmaceutical Orally Disintegrating Tablet Excipient Products Offered
10.15.5 Anhui Sunhere Pharmaceutical Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Orally Disintegrating Tablet Excipient Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Orally Disintegrating Tablet Excipient Industrial Chain Analysis
11.4 Orally Disintegrating Tablet Excipient Market Dynamics
11.4.1 Orally Disintegrating Tablet Excipient Industry Trends
11.4.2 Orally Disintegrating Tablet Excipient Market Drivers
11.4.3 Orally Disintegrating Tablet Excipient Market Challenges
11.4.4 Orally Disintegrating Tablet Excipient Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Orally Disintegrating Tablet Excipient Distributors
12.3 Orally Disintegrating Tablet Excipient Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Binders
Table 2. Major Company of Glidents
Table 3. Major Company of Diluents
Table 4. Major Company of Disintegrants
Table 5. Major Company of Others
Table 6. Global Orally Disintegrating Tablet Excipient Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 7. Global Orally Disintegrating Tablet Excipient Sales by Type (2018-2024) & (K MT)
Table 8. Global Orally Disintegrating Tablet Excipient Sales Market Share in Volume by Type (2018-2024)
Table 9. Global Orally Disintegrating Tablet Excipient Sales by Type (2018-2024) & (US& Million)
Table 10. Global Orally Disintegrating Tablet Excipient Market Share in Value by Type (2018-2024)
Table 11. Global Orally Disintegrating Tablet Excipient Price by Type (2018-2024) & (USD/MT)
Table 12. Global Orally Disintegrating Tablet Excipient Sales by Type (2024-2034) & (K MT)
Table 13. Global Orally Disintegrating Tablet Excipient Sales Market Share in Volume by Type (2024-2034)
Table 14. Global Orally Disintegrating Tablet Excipient Sales by Type (2024-2034) & (US$ Million)
Table 15. Global Orally Disintegrating Tablet Excipient Sales Market Share in Value by Type (2024-2034)
Table 16. Global Orally Disintegrating Tablet Excipient Price by Type (2024-2034) & (USD/MT)
Table 17. North America Orally Disintegrating Tablet Excipient Sales by Type (2018-2024) & (K MT)
Table 18. North America Orally Disintegrating Tablet Excipient Sales by Type (2018-2024) & (US$ Million)
Table 19. Europe Orally Disintegrating Tablet Excipient Sales (K MT) by Type (2018-2024)
Table 20. Europe Orally Disintegrating Tablet Excipient Sales by Type (2018-2024) & (US$ Million)
Table 21. Asia-Pacific Orally Disintegrating Tablet Excipient Sales (K MT) by Type (2018-2024)
Table 22. Asia-Pacific Orally Disintegrating Tablet Excipient Sales by Type (2018-2024) & (US$ Million)
Table 23. Latin America Orally Disintegrating Tablet Excipient Sales (K MT) by Type (2018-2024)
Table 24. Latin America Orally Disintegrating Tablet Excipient Sales by Type (2018-2024) & (US$ Million)
Table 25. Middle East and Africa Orally Disintegrating Tablet Excipient Sales (K MT) by Type (2018-2024)
Table 26. Middle East and Africa Orally Disintegrating Tablet Excipient Sales by Type (2018-2024) & (US$ Million)
Table 27. Global Orally Disintegrating Tablet Excipient Sales by Company (2018-2024) & (K MT)
Table 28. Global Orally Disintegrating Tablet Excipient Sales Share by Company (2018-2024)
Table 29. Global Orally Disintegrating Tablet Excipient Revenue by Company (2018-2024) & (US$ Million)
Table 30. Global Orally Disintegrating Tablet Excipient Revenue Share by Company (2018-2024)
Table 31. Global Market Orally Disintegrating Tablet Excipient Price by Company (2018-2024) & (USD/MT)
Table 32. Global Orally Disintegrating Tablet Excipient Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 33. Global Orally Disintegrating Tablet Excipient Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 34. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Orally Disintegrating Tablet Excipient as of 2022)
Table 35. Date of Key Manufacturers Enter into Orally Disintegrating Tablet Excipient Market
Table 36. Key Manufacturers Orally Disintegrating Tablet Excipient Product Type
Table 37. Mergers & Acquisitions, Expansion Plans
Table 38. Global Orally Disintegrating Tablet Excipient Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 39. Global Orally Disintegrating Tablet Excipient Sales by Region (2018-2024) & (K MT)
Table 40. Global Orally Disintegrating Tablet Excipient Sales Market Share in Volume by Region (2018-2024)
Table 41. Global Orally Disintegrating Tablet Excipient Sales by Region (2018-2024) & (US$ Million)
Table 42. Global Orally Disintegrating Tablet Excipient Sales Market Share in Value by Region (2018-2024)
Table 43. Global Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 44. Global Orally Disintegrating Tablet Excipient Sales by Region (2024-2034) & (K MT)
Table 45. Global Orally Disintegrating Tablet Excipient Sales Market Share in Volume by Region (2024-2034)
Table 46. Global Orally Disintegrating Tablet Excipient Sales by Region (2024-2034) & (US$ Million)
Table 47. Global Orally Disintegrating Tablet Excipient Sales Market Share in Value by Region (2024-2034)
Table 48. Global Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2024-2034)
Table 49. Global Orally Disintegrating Tablet Excipient Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 50. Global Orally Disintegrating Tablet Excipient Sales by Application (2018-2024) & (K MT)
Table 51. Global Orally Disintegrating Tablet Excipient Sales Market Share in Volume by Application (2018-2024)
Table 52. Global Orally Disintegrating Tablet Excipient Sales by Application (2018-2024) & (US$ Million)
Table 53. Global Orally Disintegrating Tablet Excipient Sales Market Share in Value by Application (2018-2024)
Table 54. Global Orally Disintegrating Tablet Excipient Price by Application (2018-2024) & (USD/MT)
Table 55. Global Orally Disintegrating Tablet Excipient Sales by Application (2024-2034) & (K MT)
Table 56. Global Orally Disintegrating Tablet Excipient Sales Market Share in Volume by Application (2024-2034)
Table 57. Global Orally Disintegrating Tablet Excipient Sales by Application (2024-2034) & (US$ Million)
Table 58. Global Orally Disintegrating Tablet Excipient Sales Market Share in Value by Application (2024-2034)
Table 59. Global Orally Disintegrating Tablet Excipient Price by Application (2024-2034) & (USD/MT)
Table 60. North America Orally Disintegrating Tablet Excipient Sales by Application (2018-2024) (K MT)
Table 61. North America Orally Disintegrating Tablet Excipient Sales by Application (2018-2024) & (US$ Million)
Table 62. Europe Orally Disintegrating Tablet Excipient Sales by Application (2018-2024) (K MT)
Table 63. Europe Orally Disintegrating Tablet Excipient Sales by Application (2018-2024) & (US$ Million)
Table 64. Asia-Pacific Orally Disintegrating Tablet Excipient Sales by Application (2018-2024) (K MT)
Table 65. Asia-Pacific Orally Disintegrating Tablet Excipient Sales by Application (2018-2024) & (US$ Million)
Table 66. Latin America Orally Disintegrating Tablet Excipient Sales by Application (2018-2024) (K MT)
Table 67. Latin America Orally Disintegrating Tablet Excipient Sales by Application (2018-2024) & (US$ Million)
Table 68. Middle East and Africa Orally Disintegrating Tablet Excipient Sales by Application (2018-2024) (K MT)
Table 69. Middle East and Africa Orally Disintegrating Tablet Excipient Sales by Application (2018-2024) & (US$ Million)
Table 70. North America Orally Disintegrating Tablet Excipient Sales by Country (2018-2024) & (K MT)
Table 71. North America Orally Disintegrating Tablet Excipient Sales Market Share in Volume by Country (2018-2024)
Table 72. North America Orally Disintegrating Tablet Excipient Sales by Country (2018-2024) & (US$ Million)
Table 73. North America Orally Disintegrating Tablet Excipient Sales Market Share in Value by Country (2018-2024)
Table 74. North America Orally Disintegrating Tablet Excipient Sales by Country (2024-2034) & (K MT)
Table 75. North America Orally Disintegrating Tablet Excipient Sales Market Share in Volume by Country (2024-2034)
Table 76. North America Orally Disintegrating Tablet Excipient Sales by Country (2024-2034) & (US$ Million)
Table 77. North America Orally Disintegrating Tablet Excipient Sales Market Share in Value by Country (2024-2034)
Table 78. Europe Orally Disintegrating Tablet Excipient Sales by Country (2018-2024) & (K MT)
Table 79. Europe Orally Disintegrating Tablet Excipient Sales Market Share in Volume by Country (2018-2024)
Table 80. Europe Orally Disintegrating Tablet Excipient Sales by Country (2018-2024) & (US$ Million)
Table 81. Europe Orally Disintegrating Tablet Excipient Sales Market Share in Value by Country (2018-2024)
Table 82. Europe Orally Disintegrating Tablet Excipient Sales by Country (2024-2034) & (K MT)
Table 83. Europe Orally Disintegrating Tablet Excipient Sales Market Share in Volume by Country (2024-2034)
Table 84. Europe Orally Disintegrating Tablet Excipient Sales by Country (2024-2034) & (US$ Million)
Table 85. Europe Orally Disintegrating Tablet Excipient Sales Market Share in Value by Country (2024-2034)
Table 86. Asia-Pacific Orally Disintegrating Tablet Excipient Sales by Region (2018-2024) & (K MT)
Table 87. Asia-Pacific Orally Disintegrating Tablet Excipient Sales Market Share in Volume by Region (2018-2024)
Table 88. Asia-Pacific Orally Disintegrating Tablet Excipient Sales by Region (2018-2024) & (US$ Million)
Table 89. Asia-Pacific Orally Disintegrating Tablet Excipient Sales Market Share in Value by Region (2018-2024)
Table 90. Asia-Pacific Orally Disintegrating Tablet Excipient Sales by Region (2024-2034) & (K MT)
Table 91. Asia-Pacific Orally Disintegrating Tablet Excipient Sales Market Share in Volume by Region (2024-2034)
Table 92. Asia-Pacific Orally Disintegrating Tablet Excipient Sales by Region (2024-2034) & (US$ Million)
Table 93. Asia-Pacific Orally Disintegrating Tablet Excipient Sales Market Share in Value by Region (2024-2034)
Table 94. Latin America Orally Disintegrating Tablet Excipient Sales by Country (2018-2024) & (K MT)
Table 95. Latin America Orally Disintegrating Tablet Excipient Sales Market Share in Volume by Country (2018-2024)
Table 96. Latin America Orally Disintegrating Tablet Excipient Sales by Country (2018-2024) & (US$ Million)
Table 97. Latin America Orally Disintegrating Tablet Excipient Sales Market Share in Value by Country (2018-2024)
Table 98. Latin America Orally Disintegrating Tablet Excipient Sales by Country (2024-2034) & (K MT)
Table 99. Latin America Orally Disintegrating Tablet Excipient Sales Market Share in Volume by Country (2024-2034)
Table 100. Latin America Orally Disintegrating Tablet Excipient Sales by Country (2024-2034) & (US$ Million)
Table 101. Latin America Orally Disintegrating Tablet Excipient Sales Market Share in Value by Country (2024-2034)
Table 102. Middle East and Africa Orally Disintegrating Tablet Excipient Sales by Country (2018-2024) & (K MT)
Table 103. Middle East and Africa Orally Disintegrating Tablet Excipient Sales Market Share in Volume by Country (2018-2024)
Table 104. Middle East and Africa Orally Disintegrating Tablet Excipient Sales by Country (2018-2024) & (US$ Million)
Table 105. Middle East and Africa Orally Disintegrating Tablet Excipient Sales Market Share in Value by Country (2018-2024)
Table 106. Middle East and Africa Orally Disintegrating Tablet Excipient Sales by Country (2024-2034) & (K MT)
Table 107. Middle East and Africa Orally Disintegrating Tablet Excipient Sales Market Share in Volume by Country (2024-2034)
Table 108. Middle East and Africa Orally Disintegrating Tablet Excipient Sales by Country (2024-2034) & (US$ Million)
Table 109. Middle East and Africa Orally Disintegrating Tablet Excipient Sales Market Share in Value by Country (2024-2034)
Table 110. BASF Company Information
Table 111. BASF Introduction and Business Overview
Table 112. BASF Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 113. BASF Orally Disintegrating Tablet Excipient Product
Table 114. BASF Recent Development
Table 115. JRS Pharma Company Information
Table 116. JRS Pharma Introduction and Business Overview
Table 117. JRS Pharma Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 118. JRS Pharma Orally Disintegrating Tablet Excipient Product
Table 119. JRS Pharma Recent Development
Table 120. Roquette Company Information
Table 121. Roquette Introduction and Business Overview
Table 122. Roquette Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 123. Roquette Orally Disintegrating Tablet Excipient Product
Table 124. Roquette Recent Development
Table 125. ABF Ingredients Company Information
Table 126. ABF Ingredients Introduction and Business Overview
Table 127. ABF Ingredients Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 128. ABF Ingredients Orally Disintegrating Tablet Excipient Product
Table 129. ABF Ingredients Recent Development
Table 130. DFE Pharma Company Information
Table 131. DFE Pharma Introduction and Business Overview
Table 132. DFE Pharma Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 133. DFE Pharma Orally Disintegrating Tablet Excipient Product
Table 134. DFE Pharma Recent Development
Table 135. Evonik Company Information
Table 136. Evonik Introduction and Business Overview
Table 137. Evonik Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 138. Evonik Orally Disintegrating Tablet Excipient Product
Table 139. Evonik Recent Development
Table 140. Merck KGaA Company Information
Table 141. Merck KGaA Introduction and Business Overview
Table 142. Merck KGaA Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 143. Merck KGaA Orally Disintegrating Tablet Excipient Product
Table 144. Merck KGaA Recent Development
Table 145. Ashland Company Information
Table 146. Ashland Introduction and Business Overview
Table 147. Ashland Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 148. Ashland Orally Disintegrating Tablet Excipient Product
Table 149. Ashland Recent Development
Table 150. Meggle Pharma Company Information
Table 151. Meggle Pharma Introduction and Business Overview
Table 152. Meggle Pharma Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 153. Meggle Pharma Orally Disintegrating Tablet Excipient Product
Table 154. Meggle Pharma Recent Development
Table 155. Shin-Etsu Company Information
Table 156. Shin-Etsu Introduction and Business Overview
Table 157. Shin-Etsu Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 158. Shin-Etsu Orally Disintegrating Tablet Excipient Product
Table 159. Shin-Etsu Recent Development
Table 160. Fuji Chemical Industries Company Information
Table 161. Fuji Chemical Industries Introduction and Business Overview
Table 162. Fuji Chemical Industries Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 163. Fuji Chemical Industries Orally Disintegrating Tablet Excipient Product
Table 164. Fuji Chemical Industries Recent Development
Table 165. McePharma (Vivesa holding) Company Information
Table 166. McePharma (Vivesa holding) Introduction and Business Overview
Table 167. McePharma (Vivesa holding) Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 168. McePharma (Vivesa holding) Orally Disintegrating Tablet Excipient Product
Table 169. McePharma (Vivesa holding) Recent Development
Table 170. Cargill Incorporated Company Information
Table 171. Cargill Incorporated Introduction and Business Overview
Table 172. Cargill Incorporated Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 173. Cargill Incorporated Orally Disintegrating Tablet Excipient Product
Table 174. Cargill Incorporated Recent Development
Table 175. Daicel Corporation Company Information
Table 176. Daicel Corporation Introduction and Business Overview
Table 177. Daicel Corporation Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 178. Daicel Corporation Orally Disintegrating Tablet Excipient Product
Table 179. Daicel Corporation Recent Development
Table 180. Anhui Sunhere Pharmaceutical Company Information
Table 181. Anhui Sunhere Pharmaceutical Introduction and Business Overview
Table 182. Anhui Sunhere Pharmaceutical Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 183. Anhui Sunhere Pharmaceutical Orally Disintegrating Tablet Excipient Product
Table 184. Anhui Sunhere Pharmaceutical Recent Development
Table 185. Key Raw Materials Lists
Table 186. Raw Materials Key Suppliers Lists
Table 187. Orally Disintegrating Tablet Excipient Market Trends
Table 188. Orally Disintegrating Tablet Excipient Market Drivers
Table 189. Orally Disintegrating Tablet Excipient Market Challenges
Table 190. Orally Disintegrating Tablet Excipient Market Restraints
Table 191. Orally Disintegrating Tablet Excipient Distributors List
Table 192. Orally Disintegrating Tablet Excipient Downstream Customers
Table 193. Research Programs/Design for This Report
Table 194. Key Data Information from Secondary Sources
Table 195. Key Data Information from Primary Sources
List of Figures
Figure 1. Orally Disintegrating Tablet Excipient Product Picture
Figure 2. Global Orally Disintegrating Tablet Excipient Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Orally Disintegrating Tablet Excipient Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Orally Disintegrating Tablet Excipient Sales Status and Outlook (2018-2034) & (K MT)
Figure 5. Product Picture of Binders
Figure 6. Global Binders Sales YoY Growth (2018-2034) & (K MT)
Figure 7. Product Picture of Glidents
Figure 8. Global Glidents Sales YoY Growth (2018-2034) & (K MT)
Figure 9. Product Picture of Diluents
Figure 10. Global Diluents Sales YoY Growth (2018-2034) & (K MT)
Figure 11. Product Picture of Disintegrants
Figure 12. Global Disintegrants Sales YoY Growth (2018-2034) & (K MT)
Figure 13. Product Picture of Others
Figure 14. Global Others Sales YoY Growth (2018-2034) & (K MT)
Figure 15. Global Orally Disintegrating Tablet Excipient Sales by Type (2018-2034) & (US$ Million)
Figure 16. Global Orally Disintegrating Tablet Excipient Sales Market Share by Type in 2022 & 2034
Figure 17. North America Orally Disintegrating Tablet Excipient Sales Market Share in Volume by Type in 2022
Figure 18. North America Orally Disintegrating Tablet Excipient Sales Market Share in Value by Type in 2022
Figure 19. Europe Orally Disintegrating Tablet Excipient Sales Market Share in Volume by Type in 2022
Figure 20. Europe Orally Disintegrating Tablet Excipient Sales Market Share in Value by Type in 2022
Figure 21. Asia-Pacific Orally Disintegrating Tablet Excipient Sales Market Share in Volume by Type in 2022
Figure 22. Asia-Pacific Orally Disintegrating Tablet Excipient Sales Market Share in Value by Type in 2022
Figure 23. Latin America Orally Disintegrating Tablet Excipient Sales Market Share in Volume by Type in 2022
Figure 24. Latin America Orally Disintegrating Tablet Excipient Sales Market Share in Value by Type in 2022
Figure 25. Middle East and Africa Orally Disintegrating Tablet Excipient Sales Market Share in Volume by Type in 2022
Figure 26. Middle East and Africa Orally Disintegrating Tablet Excipient Sales Market Share in Value by Type in 2022
Figure 27. The 5 and 10 Largest Manufacturers in the World: Market Share by Orally Disintegrating Tablet Excipient Sales in 2022
Figure 28. The 5 and 10 Largest Manufacturers in the World: Market Share by Orally Disintegrating Tablet Excipient Revenue in 2022
Figure 29. Orally Disintegrating Tablet Excipient Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 30. Product Picture of Anti-Psychotics Drug
Figure 31. Global Anti-Psychotics Drug Sales YoY Growth (2018-2034) & (K MT)
Figure 32. Product Picture of Anti-Epileptics Drug
Figure 33. Global Anti-Epileptics Drug Sales YoY Growth (2018-2034) & (K MT)
Figure 34. Product Picture of Others
Figure 35. Global Others Sales YoY Growth (2018-2034) & (K MT)
Figure 36. Global Orally Disintegrating Tablet Excipient Sales by Application (2018-2034) & (US$ Million)
Figure 37. Global Orally Disintegrating Tablet Excipient Sales Market Share by Application in 2022 & 2034
Figure 38. North America Orally Disintegrating Tablet Excipient Sales Market Share in Volume by Application in 2022
Figure 39. North America Orally Disintegrating Tablet Excipient Sales Market Share in Value by Application in 2022
Figure 40. Europe Orally Disintegrating Tablet Excipient Sales Market Share in Volume by Application in 2022
Figure 41. Europe Orally Disintegrating Tablet Excipient Sales Market Share in Value by Application in 2022
Figure 42. Asia-Pacific Orally Disintegrating Tablet Excipient Sales Market Share in Volume by Application in 2022
Figure 43. Asia-Pacific Orally Disintegrating Tablet Excipient Sales Market Share in Value by Application in 2022
Figure 44. Latin America Orally Disintegrating Tablet Excipient Sales Market Share in Volume by Application in 2022
Figure 45. Latin America Orally Disintegrating Tablet Excipient Sales Market Share in Value by Application in 2022
Figure 46. Middle East and Africa Orally Disintegrating Tablet Excipient Sales Market Share in Value by Application in 2022
Figure 47. Key Raw Materials Price
Figure 48. Orally Disintegrating Tablet Excipient Manufacturing Cost Structure
Figure 49. Orally Disintegrating Tablet Excipient Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries